Pharmacologic regimens for knee osteoarthritis prevention: Can they be cost-effective?

OBJECTIVE: We sought to determine the target populations and drug efficacy, toxicity, cost, and initiation age thresholds under which a pharmacologic regimen for knee osteoarthritis (OA) prevention could be cost-effective. DESIGN: We used the Osteoarthritis Policy (OAPol) Model, a validated state-tr...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Losina, Elena, Burbine, Sara A., Suter, Lisa G., Hunter, David J., Solomon, Daniel H., Daigle, Meghan E., Dervan, Elizabeth E., Jordan, Joanne M., Katz, Jeffrey N.
Format: Artigo
Langue:Inglês
Publié: 2014
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4006219/
https://ncbi.nlm.nih.gov/pubmed/24487044
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.joca.2014.01.005
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires